Ratings and target prices
Most analysts recommend “hold” for Kimberly-Clark (KMB) and Colgate-Palmolive (CL) stock. Both companies’ top and bottom lines are expected to fall in the near term, reflecting currency fluctuation, increased input and logistics costs, and a higher effective tax rate. Competition could further pressure their sales and earnings.
Of the 18 analysts covering Kimberly-Clark stock, 13 recommend “hold,” four recommend “sell,” and one recommends “buy.” Their average target price of $109.13 for KMB implies a 10.6% downside based on its March 22 closing price of $122.05.
Meanwhile, of the 23 analysts covering CL stock, 14 recommend “hold,” six recommend “buy,” and three recommend “sell.” Their average target price of $64.60 for CL implies a 2.1% downside based on its March 22 closing price of $66.